Genetic testing can tell you what your patients can’t
What is the GeneSight® test?
The GeneSight Psychotropic test is a pharmacogenomic test that analyzes clinically important genetic variations which may impact how your patient metabolizes and responds to certain medications used to treat depression, anxiety, ADHD, and other psychiatric conditions.
The test is a powerful tool to augment your knowledge, experience, and passion for your patients.
Tens of thousands of clinicians have ordered the GeneSight test for
0
patients and counting
A Comprehensive Report, Personalized for your Patient.
The GeneSight Psychotropic report may help you avoid multiple medication trials by providing information about which medications may require dose adjustments, be less likely to work, or have an increased risk of side effects based on your patient’s genetic information.
The report also includes information on how a patient’s smoking status may affect their body’s metabolism of certain medications.
Cost shouldn’t be a barrier to the GeneSight test.
Our goal is to make the GeneSight test affordable and accessible to patients. Insurance can be complicated, and we want you to feel comfortable ordering the test for your patients.
We will bill your patient’s insurance for the cost of the GeneSight test:
| Medicare (Part B) Covered Tests | $0 out of pocket cost for your patient |
| Medicaid | Typically, $0 out of pocket cost |
| Medicare Advantage Covered Tests | Patient may be expected to cover a portion of the cost (typically $330 or less) |
| Commercial or Other | |
| Uninsured | Learn more at genesight.com/uninsured or contact our customer service team at 866.757.9204 |
We also offer a payment plan and a financial assistance program to help patients with their out of pocket cost. Learn more about these programs on our Cost page.
The GeneSight Promise
We do our best to make the GeneSight test affordable for your patients. We promise that if your patient’s cost could be more than $330, we will call them before we process their test.
Over
95%
of patients pay
$330
or less
Who Can Benefit from the GeneSight test?
Fewer than 50% of patients with depression respond to their first prescribed medication and with each failed medication trial, their treatment intolerance increases.1
Consider offering the GeneSight test to:
 |
New patients with a previous medication failure |
|
Patients who are experiencing lower than desired medication response |
|
Patients who are currently experiencing unwanted side effects |
|
Elderly patients and patients with liver damage |
| 7 |
clinical studies published in peer-reviewed journals support the GeneSight test’s effectiveness.In fact it’s the only psychiatric pharmacogenomic test backed by such extensive research. |
In a post-hoc analysis of data from the GUIDED study, the GeneSight Psychotropic test was found to significantly improve clinical outcomes in patients taking medications with gene-drug interactions compared to treatment as usual.1
 |
Remission: 70% relative improvement and 7% absolute improvement in remission rates |
|
Response: 42% relative improvement and 8% absolute improvement in response rates |
|
Symptom Improvement: 23% relative improvement and 5% absolute improvement in symptoms |
1. Thase ME, et al. 2019 J Clin Psychiatry
Ready to offer your patients the GeneSight Test?
Get started by filling out this form or calling us at 866.757.9204. Once registered, ordering the test is simple.
STEP 1
Place your order on myGeneSight.com
STEP 2
You or a member of your staff collect the patient’s DNA sample with a simple cheek swab OR your patient collects the sample at home using our patient collection kit
STEP 3
Your patient’s sample is sent to our lab for analysis. After the sample is received, result are typically available in about 2 days
STEP 4
Use the genetic insights from the GeneSight report to inform your treatment
Hear From Others Like You
No shortcode ID found
The stories shared on this page are individual healthcare providers’ personal experiences with GeneSight. Others may not have the same experience or outcome. Do not make any changes to your current medications or dosing without consulting your healthcare provider.
Cost shouldn’t be a barrier to the GeneSight test.
Our goal is to make the GeneSight test affordable and accessible to patients. Insurance can be complicated, and we want you to feel comfortable ordering the test for your patients.
We will bill your patient’s insurance for the cost of the GeneSight test:
| Medicare (Part B) Covered Tests | $0 out of pocket cost for your patient |
| Medicaid | Typically, $0 out of pocket cost |
| Medicare Advantage Covered Tests | Patient may be expected to cover a portion of the cost (typically $330 or less) |
| Commercial or Other | |
| Uninsured | Learn more at genesight.com/uninsured or contact our customer service team at 866.757.9204 |
We also offer a payment plan and a financial assistance program to help patients with their out of pocket cost. Learn more about these programs on our Cost page.
The GeneSight Promise
We do our best to make the GeneSight test affordable for your patients. We promise that if your patient’s cost could be more than $330, we will call them before we process their test.
Over
0
of patients pay
0
or less
Who Can Benefit from the GeneSight test?
Fewer than 50% of patients with depression respond to their first prescribed medication and with each failed medication trial, their treatment intolerance increases.1
Consider offering the GeneSight test to:
|
New patients with a previous medication failure |
|
Patients who are experiencing lower than desired medication response |
|
Patients who are currently experiencing unwanted side effects |
|
Elderly patients and patients with liver damage |
| 7 |
clinical studies published in peer-reviewed journals support the GeneSight test’s effectiveness.In fact it’s the only psychiatric pharmacogenomic test backed by such extensive research. |
In a post-hoc analysis of data from the GUIDED study, the GeneSight Psychotropic test was found to significantly improve clinical outcomes in patients taking medications with gene-drug interactions compared to treatment as usual.1
|
Remission: 70% relative improvement and 7% absolute improvement in remission rates |
|
Response: 42% relative improvement and 8% absolute improvement in response rates |
|
Symptom Improvement: 23% relative improvement and 5% absolute improvement in symptoms |
1. Thase ME, et al. 2019 J Clin Psychiatry
Ready to offer your patients the GeneSight Test?
Get started by filling out this form or calling us at 866.757.9204. Once registered, ordering the test is simple.
STEP 1
Place your order on myGeneSight.com
STEP 2
You or a member of your staff collect the patient’s DNA sample with a simple cheek swab OR your patient collects the sample at home using our patient collection kit
STEP 3
Your patient’s sample is sent to our lab for analysis. After the sample is received, result are typically available in about 2 days
STEP 4
Use the genetic insights from the GeneSight report to inform your treatment
